Orbimed Advisors LLC Biomarin Pharmaceutical Inc Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $93.2 Million - $115 Million	-1,252,400 Reduced 97.96%	26,100 $2.15 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $24.5 Million - $29 Million	-292,910 Reduced 18.64%	1,278,500 $112 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $3.34 Million - $4.31 Million	-43,800 Reduced 2.71%	1,571,410 $152 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $8.26 Million - $11.1 Million	-102,100 Reduced 5.95%	1,615,210 $167 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $1.45 Million - $1.71 Million	17,600 Added 1.04%	1,717,310 $146 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $3.77 Million - $4.58 Million	52,680 Added 3.2%	1,699,710 $141 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $58.4 Million - $72.9 Million	786,150 Added 91.32%	1,647,030 $127 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $53.8 Million - $68.6 Million	749,980 Added 676.27%	860,880 $76.1 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $8.29 Million - $9.48 Million	110,900 New	110,900 $8.57 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $43 Million - $67.1 Million	-540,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $36.1 Million - $49 Million	505,800 Added 1457.64%	540,500 $45.7 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $2.23 Million - $3 Million	34,700 New	34,700 $2.93 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $5.06 Million - $6.38 Million	-75,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $120,524 - $140,850	-1,500 Reduced 1.96%	75,000 $6.42 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $5.24 Million - $6.83 Million	-69,000 Reduced 47.42%	76,500 $7.21 Million
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $3.49 Million - $4.16 Million	44,900 Added 44.63%	145,500 $11.8 Million
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $52 Million - $61.2 Million	-643,300 Reduced 86.48%	100,600 $8.97 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $60 Million - $70.6 Million	743,900	743,900 $69.2 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.48 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.25 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.23 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$903 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$682 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account